Stay updated on IBI310 and IBI308 vs High-Dose Interferon in Acral Melanoma Clinical Trial
Sign up to get notified when there's something new on the IBI310 and IBI308 vs High-Dose Interferon in Acral Melanoma Clinical Trial page.

Latest updates to the IBI310 and IBI308 vs High-Dose Interferon in Acral Melanoma Clinical Trial page
- Check7 days agoChange DetectedA new revision entry, v3.5.3, was added to the history. The previous revision, v3.5.2, was removed from the current list.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 from the history.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check50 days agoChange DetectedThe record history now includes revision v3.5.0 and removes the previous v3.4.3.SummaryDifference0.1%

- Check57 days agoChange DetectedA new revision entry v3.4.3 was added to the history and the previous revision v3.4.2 was removed.SummaryDifference0.1%

- Check86 days agoChange DetectedA new site revision (v3.4.2) was added; previous notices about funding/operating status and v3.4.1 were removed.SummaryDifference0.9%

- Check93 days agoChange DetectedAdded a time-sensitive government funding notice about the NIH Clinical Center's status and updated the history to revision v3.4.1, with v3.4.0 removed.SummaryDifference0.9%

Stay in the know with updates to IBI310 and IBI308 vs High-Dose Interferon in Acral Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IBI310 and IBI308 vs High-Dose Interferon in Acral Melanoma Clinical Trial page.